$bluebird bio (BLUE.US)$ Bluebird Bio Issues LYFGENIA Boxed ...
Bluebird Bio Issues LYFGENIA Boxed Warning: Hematologic Malignancy Has Occurred In Patients Treated With The Drug; Patients Should Monitor For Evidence Of Malignancy Through Complete Blood Counts At Least Every 6 Months, Through Integration Site Analysis
Bluebird Bio 发布了 LYFGENIA 盒装警告：接受该药物治疗的患者中出现了血液学恶性肿瘤；患者应通过整合位点分析，至少每 6 个月通过全血细胞计数监测恶性证据
所以大幅下跌
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jaguar8 : How many participants from the pool got hematologist malignancy?
It is best to put your source when you publicize such claims